Pioglitazone Tablet
Product Images NDC 50090-4605

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pioglitazone (NDC 50090-4605). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label Image (Lbl500904605)

Label Image (Lbl500904605)
FDA Label Image

Figure 1. Mean Change From Baseline For Hba1c In A 26-week Placebo-controlled Dose-ranging Study (observed Values) (Pioglitazone Fig1)

Figure 1. Mean Change From Baseline For Hba1c In A 26-week Placebo-controlled Dose-ranging Study (observed Values) (Pioglitazone Fig1)
The image shows a graph representing the mean change from baseline for HbAlc in a 26-week placebo-controlled dose-ranging study for three different doses (15mg, 30mg, and 45mg). The X-axis indicates the number of weeks, and the Y-axis shows the mean change percentage. It appears that all three doses led to a decrease in HbAlc levels over the 26 weeks.*
FDA Label Image

Chemical Structure (Pioglitazone Str)

Chemical Structure (Pioglitazone Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.